Case Overview

Search Import Questions Import Conditions Onshore Outcomes

Case: Human therapeutics and medicines Effective: 04 May 2023 to 01 Aug 2023

Case Description

This case describes the requirements for the importation of human therapeutics and medicines. This case includes human material for human therapeutic use e.g. organs for transplant, blood products for transfusions. This case may include, but is not limited to, complementary medicines (including Chinese medicines) containing animal and/or microbial derived material.

Alerts

1 Active Alert(s) View

2 Active Change Notice(s) View

This case applies to imports into: Australia.

Warnings and Information Notices

Some products may require specialised storage and/or handling.